HIV-1 CRF02_AG accounts for >50% of infected individuals in Cameroon. CRF02_AG prevalence has been increasing both in Africa and Europe, particularly in Italy because of migrations from the sub-Saharan region. This study investigated the molecular epidemiology of CRF02_AG in Cameroon by employing Bayesian phylodynamics and analyzed the relationship between HIV-1 CRF02_AG isolates circulating in Italy and those prevalent in Africa to understand the link between the two epidemics. Among 291 Cameroonian reverse transcriptase sequences analyzed, about 70% clustered within three distinct clades, two of which shared a most recent common ancestor, all related to sequences from Western Africa. The major Cameroonian clades emerged during the mid-1970s and slowly spread during the next 30 years. Little or no geographic structure was detected within these clades. One of the major driving forces of the epidemic was likely the high accessibility between locations in Southern Cameroon contributing to the mobility of the population. The remaining Cameroonian sequences and the new strains isolated from Italian patients were interspersed mainly within West and Central African sequences in the tree, indicating a continuous exchange of CRF02_AG viral strains between Cameroon and other African countries, as well as multiple independent introductions in the Italian population. The evaluation of the spread of CRF02_AG may provide significant insight about the future dynamics of the Italian and European epidemic.
Get full access to this article
View all access options for this article.
References
1.
HIV Sequence Database. http://www.hiv.lanl.gov/content/sequence/HIV/mainpage.html.
2.
AIDS epidemic update: Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO)2009. http://www.unaids.org/en/default.asp.
3.
NkengasongJN, JanssensW, HeyndrickxLet al.Genotypic subtypes of HIV-1 in Cameroon. AIDS, 1994; 8:1405–1412.
4.
MauclèreP, Loussert-AjakaI, DamondFet al.Serological and virological characterization of HIV-1 group O infection in Cameroon. AIDS, 1997; 11:445–453.
5.
SimonF, MauclereP, RoquesPet al.Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med, 1998; 4:1032–1037.
6.
TakehisaJ, ZekengL, IdoEet al.Human immunodeficiency virus type 1 intergroup (M/O) recombination in Cameroon. J Virol, 1999; 73:6810–6820.
7.
TriquesK, BourgeoisA, VidalNet al.Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K. AIDS Res Hum Retroviruses, 2000; 16:139–151.
8.
CarrJK, TorimiroJN, NathanDW, MpoudiNEet al.Novel HIV-1 forms are common in Cameroon. Virology, 2001; 286:168–181.
9.
CarrJK, WolfeND, TorimiroJNet al.HIV-1 recombinants with multiple parental strains in low-prevalence, remote regions of Cameroon: Evolutionary relics?Retrovirology, 2010; 28:7–39.
10.
KoningsFA, HamanGR, XueYet al.Genetic analysis of HIV-1 strains in rural eastern Cameroon indicates the evolution of second-generation recombinants to circulating recombinant forms. J Acquir Immune Defic Syndr, 2006; 42:331–341.
11.
PowellRL, ZhaoJ, KoningsFAet al.Circulating recombinant form (CRF) 37_cpx: An old strain in Cameroon composed of diverse, genetically distant lineages of subtypes A and G. AIDS Res Hum Retroviruses, 2007; 23:923–933.
12.
PowellRL, ZhaoJ, KoningsFAet al.Identification of a novel circulating recombinant form (CRF) 36_cpx in Cameroon that combines two CRFs (01_AE and 02_AG) with ancestral lineages of subtypes A and G. AIDS Res Hum Retroviruses, 2007; 23:1008–1019.
13.
BrennanCA, BodelleP, CoffeyRet al.The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004. J Acquir Immune Defic Syndr, 2008; 49:432–439.
14.
NdembiN, AbrahaA, PilchHet al.Molecular characterization of HIV-1 and HIV-2 in Yaoundé, Cameroon: Evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. J Clin Microbiol, 2008; 46:177–184.
15.
TorimiroJN, D'ArrigoR, TakouDet al.Human immunodeficiency virus type 1 intersubtype recombinants predominate in the AIDS epidemic in Cameroon. New Microbiol, 2009; 32:325–332.
16.
YamaguchiJ, NdembiN, NgansopCet al.HIV type 1 group M subtype G in Cameroon: Five genome sequences. AIDS Res Hum Retroviruses, 2009; 25:469–473.
17.
VallariA, BodelleP, NgansopCet al.Four new HIV-1 group N isolates from Cameroon: Prevalence continues to be low. AIDS Res Hum Retroviruses, 2010; 26:109–115.
18.
Garcia-CallejaJM, ZekengL, LouisJPet al.HIV infection in Cameroon: 30 months' surveillance in Yaounde. AIDS, 1992; 6:881–882.
19.
PeetersM. Recombinant HIV sequences: Their role in the global epidemic. HIV Sequence Compendium, 2000KuikenCLet al.Theoretical Biophysics Group, Los Alamos National Laboratory: Los Alamos, NM, 2000; I-39–54.
20.
FischettiL, Opare-SemO, CandottiD, LeeH, AllainJP. Higher viral load may explain the dominance of CRF02_AG in the molecular epidemiology of HIV in Ghana. AIDS, 2004; 18:1208–1210.
21.
FischettiL, Opare-SemO, CandottiD, SarkodieF, LeeH, AllainJP. Molecular epidemiology of HIV in Ghana: Dominance of CRF02_AG. J Med Virol, 2004; 73:158–166.
22.
SarrAD, EisenG, Gueye-NdiayeAet al.Viral dynamics of primary HIV-1 infection in Senegal, West Africa. J Infect Dis, 2005; 191:1460–1467.
23.
NjaiHF, GaliY, VanhamGet al.The predominance of human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness. Retrovirology, 2006; 3:1–11.
24.
OrtizM, MuñozL, BernalAet al.Molecular characterization of non-B HIV type 1 subtypes from Africa in Spain. AIDS Res Hum Retroviruses, 2000; 16:1967–1971.
25.
ParreiraR, PáduaE, PiedadeJ, VenennoT, PaixãoMT, EstevesA. Genetic analysis of human immunodeficiency virus type 1 nef in Portugal: Subtyping, identification of mosaic genes, and amino acid sequence variability. J Med Virol, 2005; 77:8–16.
26.
FalkensammerB, DoerlerM, KesslerHHet al.Subtype and genotypic resistance analysis of HIV-1 infected patients in Austria. Wien Klin Wochenschr, 2007; 119:181–185.
27.
ThomsonMM, DelgadoE, HerreroIet al.Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences. J Gen Virol, 2002; 83:107–119.
28.
MonnoL, BrindicciG, Lo CaputoSet al.HIV-1 subtypes and circulating recombinant forms (CRFs) from HIV-infected patients residing in two regions of central and southern Italy. J Med Virol., 2005; 75:483–490.
29.
TramutoF, BonuraF, PernaAMet al.Group for HIV-1 Antiretroviral Studies in Sicily. Genetic diversity of HIV-1 non-B strains in Sicily: Evidence of intersubtype recombinants by sequence analysis of gag, pol, and env genes. AIDS Res Hum Retroviruses, 2007; 23:1131–1138.
30.
SantoroMM, AlteriC, RongaLet al.Evaluation of HIV-1 non-B subtypes in Italian treated patients from central Italy over the years 2001–2008. 7th European HIV Drug Resistance workshop: Stockholm, Sweden, 25–27March2009Abstract 130.
31.
BraccialeL, ColafigliM, ZazziMet al.Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: Evolution over 12 years and predictors. J Antimicrob Chemother, 2009; 64:607–615.
32.
TortiC, LapadulaG, IzzoIet al.Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: Public health implications. Epidemiol Infect, 2010; 29:1–10.
33.
HemelaarJ, GouwsE, GhysPD, OsmanovS. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS, 2006; 20:W13–23.
34.
FelsensteinJ. Accuracy of coalescent likelihood estimates: Do we need more sites, more sequences, or more loci?Mol Biol Evol, 2006; 23:691–700.
35.
Ceccherini-SilbersteinF, ErbaF, GagoFet al.Identification of the minimal conserved structure of HIV-1 protease in the presence or absence of drug pressure. AIDS, 2004; 18:11–19.
36.
GiulianiM, MontieriS, PalamaraGet al.Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy. AIDS Res Hum Retroviruses, 2009; 25:157–164.
37.
ThompsonJD, HigginsDG, GibsonTJ. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res, 1994; 22:4673–4680.
38.
GuindonS, GascuelO. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol, 2003; 52:696–704.
39.
SwoffordDL, SullivanJ. Phylogeny inference based on parsimony, other methods using PAUP*The Phylogenetic Handbook: A Practical Approach to Phylogenetic Analysis and Hypothesis Testing, 2ndLemeyP, SalemiM, VandammeAM. Cambridge University Press: New York, 2009; 267–312.
40.
AnisimovaM, GascuelO. Approximate likelihood-ratio test for branches: A fast, accurate, and powerful alternative. Syst Biol, 2006; 55:539–552.
SlatkinM. Detecting small amounts of gene flow from phylogenies of alleles. Genetics, 1989; 121:609–612.
46.
SalemiM, LamersSL, YuS, de OliveiraT, FitchWM, McGrathMS. Phylodynamic analysis of human immunodeficiency virus type 1 in distinct brain compartments provides a model for the neuropathogenesis of AIDS. J Virol, 2005; 79:11343–11352.
NelsonA. Estimated travel time to the nearest city of 500,000 or more people in year. 2000. Vol.http://gem.jrc.ec.europa.eu. 2009 02 17Global Environment Monitoring Unit–Joint Research Centre of the European Commission: Ispra, Italy, 2008.
49.
GrayRR, TatemAJ, LamersSet al.Spatial phylodynamics of HIV-1 epidemic emergence in east Africa. AIDS, 2009; 23:F9–F17.
50.
NdongmoCB, PieniazekD, Holberg-PetersenMet al.HIV genetic diversity in Cameroon: Possible public health importance. AIDS Res Hum Retroviruses, 2006; 22:812–816.
51.
ThomsonMM, NajeraR. Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into western countries. Clin Infect Dis, 2001; 32:1732–1737.
52.
KantorR. Impact of HIV-1 pol diversity on drug resistance and its clinical implications. Curr Opin Infect Dis, 2006; 19:594–606.
53.
BuonaguroL, TorneselloML, BuonaguroFM. Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: Pathogenetic and therapeutic implications. J Virol, 2007; 81:10209–10219.
54.
TaylorBS, TaylorBS, SobieszczykME, McCutchanFE, HammerSM. The challenge of HIV-1 subtype diversity. N Engl J Med, 2008; 358:1590–1602.
55.
EasterbrookPJ, SmithM, MullenJet al.Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy. J Int AIDS Soc, 2010; 13:2–9.
56.
PeetersM, Toure-KaneC, NkengasongJN. Genetic diversity of HIV in Africa: Impact on diagnosis, treatment, vaccine development and trials. AIDS, 2003; 17:2547–2560.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
